日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis

抗白细胞介素-17抗体时代生物制剂的生存率:一项经时间调整的注册研究分析

Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, P G; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P

Anti-psoriatic therapy recovers high-density lipoprotein composition and function

抗银屑病治疗可恢复高密度脂蛋白的组成和功能

Michael Holzer, Peter Wolf, Martin Inzinger, Markus Trieb, Sanja Curcic, Lisa Pasterk, Wolfgang Weger, Akos Heinemann, Gunther Marsche

Allopurinol in the treatment of acquired reactive perforating collagenosis

别嘌醇治疗获得性反应性穿孔性胶原病

Tilz, Hemma; Becker, Jürgen Christian; Legat, Franz; Schettini, Antonio Pedro Mendes; Inzinger, Martin; Massone, Cesare

Psoriasis alters HDL composition and cholesterol efflux capacity

牛皮癣会改变高密度脂蛋白 (HDL) 成分和胆固醇流出能力

Michael Holzer, Peter Wolf, Sanja Curcic, Ruth Birner-Gruenberger, Wolfgang Weger, Martin Inzinger, Dalia El-Gamal, Christian Wadsack, Akos Heinemann, Gunther Marsche